
Baricitinib Is Safe and Effective for Treating Systemic Lupus Erythematosus
A systematic review and meta-analysis of three studies with 1849 participants found that treatment with the Janus kinase inhibitor baricitinib was safe and effective for treating systemic lupus erythematosus (SLE). Baricitinib increased the chances of achieving a Systemic Lupus Erythematosus Responder Index-4 response and reducing Systemic Lupus Erythematosus Disease Activity Index-2000 scores. Additionally, patients treated…